Recommended Conferences for Pulmonary Medicine

Name: 6th Annual Meeting on Infectious Diseases, Microbiology & Beneficial Microbes
Start: 2025-06-24
End: 2025-06-26
Location: Paris,France

2024-11-28

12th International Conference On Infectious Diseases, Bacteriology And Antibiotics

Paris, France

2025-06-02

14th World Congress On Rare Diseases And Orphan Drugs

Amsterdam, Netherlands

2025-06-02

17th Euro-Global Conference On Infectious Diseases

Amsterdam, Netherlands

2025-06-16

5th International Conference On Microbiology And Infectious Diseases

Amsterdam, Netherlands

2025-06-24

6th Annual Meeting On Infectious Diseases, Microbiology & Beneficial Microbes

Paris, France

Pulmonary Medicine

As per available reports about 69 relevant journals, 35 Conferences, 1597 workshops are presently dedicated exclusively to breathing disorder and about 5575 articles are being published on Infectious Diseases.

The Pulmonary Medicine is the branch of medicine that deals with the causes, diagnosis, prevention and treatment of diseases affecting the lungs evaluates and threats people with diseases of the lungs and the other organs of breathing. In actual fact these medicines treat diseases in the chest other than the heart. Pulmonary medicine is also known as Chest medicine, Respiratory medicine/ Thoracic medicine etc. It treats diseases like Asthma, Chronic Bronchitis, Tuberculosis, Rhinomanometry etc. Pulmonary Medicine Conference provides the scope for opportunities to learn progressed by international scientists and academicians. Pulmonary medicine is also sometimes called pulmonology which is the science concerned with the anatomy, physiology, and pathology of the lungs. Pulmonary Medicine Conference offers excessive quality content to suit the diverse professional development of these medicines to treat people all over the globe.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance

Pulmonary Medicine conference is a perfect platform to discuss the current discoveries and developments in the field of Pulmonology. The National Symposium on Pulmonary medicines offers an opportunity for a diverse group of attendees to network, compare programs, learn about new approaches, and discuss the latest issues facing the development in the field of pulmonology. The conference is is a platform where doctors, clinicians, researchers, health policy makers, physicians, nurses and health professionals can interact and discuss the current and future scenario in the field of pulmonary medicines. The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. The ATS is a founding member of FIRS (Forum of International Respiratory Societies). ATS has grown into an international society with more than 15,000 members.

Market Analysis

Infectious diseases therapeutic market

The infectious diseases therapeutic market in US is estimated to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to infectious diseases globally. Current market trend shows that North America has the more global market for infectious diseases therapeutics due to increasing incidence of infectious diseases and due to rise in aging population. Followed by North America highest global market is expected in Asia then followed by the Europe in the global infectious diseases therapeutics market. In Asia-Pacific region, China and India are expected to be the fastest growing infectious diseases therapeutics markets. The main reasons behind the highest global market of infectious diseases therapeutics market in the above countries is mainly due to large number of patients and due to increase in government funding. Some of the major companies playing a key role in the global infectious diseases therapeutics market are Merck & Co., Pfizer, Johnson & Johnson, F. Hoffmann-La Roche, GlaxoSmithKline Pharmaceutical, Inc., Auritec Pharmaceuticals, Novartis, Achillion Pharmaceuticals, Isis Pharmaceuticals and Gilead Sciences.

Infectious diseases diagnostics market

Market for infectious disease molecular diagnostics tests includes hospitals, blood banks, reference laboratories. North America has the highest global market for molecular diagnostics tests followed by Europe due to the market availability of the tests and high occurrence rate of various infectious diseases such as HPV, hepatitis and bacterial infections. Asia Pacific, Latin America and Middle East are expected to be the potential markets in the coming years. Major companies which play a key role in infectious disease molecular diagnostics tests market are Abbott Laboratories, Affymetrix, Inc., Becton, Dickinson and Company, bioMérieux, Cepheid, Inc., Hologic, Inc., Life Technologies, Myriad Genetics, Inc., Qiagen N.V. and others.